KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2016 - 2025)

Acadia Pharmaceuticals has reported Asset Utilization Ratio over the past 15 years, most recently at 0.74 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.74 for Q4 2025, down 16.35% from a year ago — trailing twelve months through Dec 2025 was 0.74 (down 16.35% YoY), and the annual figure for FY2025 was 0.78, down 21.27%.
  • Asset Utilization Ratio for Q4 2025 was 0.74 at Acadia Pharmaceuticals, down from 0.82 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ACAD hit a ceiling of 1.05 in Q4 2023 and a floor of 0.6 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.85 (2023), compared with a mean of 0.84.
  • Biggest five-year swings in Asset Utilization Ratio: surged 32.27% in 2022 and later fell 16.64% in 2025.
  • Acadia Pharmaceuticals' Asset Utilization Ratio stood at 0.68 in 2021, then rose by 27.25% to 0.87 in 2022, then increased by 21.01% to 1.05 in 2023, then decreased by 15.85% to 0.88 in 2024, then dropped by 16.35% to 0.74 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.74 (Q4 2025), 0.82 (Q3 2025), and 0.86 (Q2 2025) per Business Quant data.